Barcelona, Spain

Enric Capdevila Urbaneja

This inventor holds 1 USPTO granted patent and 1 published patent application and 4 EPO patents. Top assignee: Inke, S.a.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Enric Capdevila Urbaneja. Retrieved from https://idiyas.com/inventor/enric-capdevila-urbaneja

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Enric Capdevila Urbaneja: Innovator in the Pharmaceutical Industry

Introduction

Enric Capdevila Urbaneja is a notable inventor based in Sant Joan Despí, Barcelona, Spain. He is currently associated with Laboratorios Lesvi, S.L., a company that specializes in pharmaceutical products. Despite having no patents to his name, his contributions to the field are significant.

Latest Patents

Enric Capdevila Urbaneja currently holds 1 patents. This indicates that his work may focus more on research and development rather than patenting inventions.

Career Highlights

Throughout his career, Enric has been involved in various projects that aim to improve pharmaceutical formulations and processes. His expertise in the industry has allowed him to contribute to advancements in healthcare solutions.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Enric Capdevila Urbaneja is a dedicated professional in the pharmaceutical industry, making strides in research and development at Laboratorios Lesvi, S.L. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…